Project Grant K08HD118259
- The National Institute of Allergy and Infectious Diseases awarded Rhode Island Hospital $195,475 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance understanding of the physiological mechanisms by which infections contribute to stunting and wasting in young children and to support career development of the principal investigator. The research leverages well-characterized samples and clinical data from a completed NIH-funded randomized,...
- The National Institute of Child Health and Human Development awarded Women & Infants Hospital of Rhode Island $248,999 on May 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to conduct a longitudinal study examining how maternal prenatal stress and nutrition intervention jointly influence child cognitive and neural development. The research leverages data from the ENAT trial, which randomized 2,390 pregnant women to receive enhanced nutrition...
- The National Institutes of Health Office of the Director awarded Women & Infants Hospital of Rhode Island $875,534 on July 6, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to study subclinical deficits in attention, executive function, and social communication in children born very preterm. The project will recruit and follow a cohort of 240 very preterm children (born before 32 weeks gestation) from the hospital's neonatal follow-up program, tracking them from ages 3...
- The National Institute of Child Health and Human Development (National Institutes of Health, Department of Health and Human Services) awarded $2,453,772 to Ann & Robert H Lurie Children's Hospital of Chicago on July 3, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the role of human milk metabolome and microRNAs on metabolic health in breastfeeding children with and without perinatal HIV exposure. The research leverages the...
- The National Institute of Child Health and Human Development awarded Brigham & Womens Hospital Inc. $498,848 under Project Grant R56HD122751 on September 1, 2026, to investigate body composition trajectories in preterm infants and their associations with neurodevelopmental and cardiometabolic outcomes. The award operates under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project examines longitudinal body composition assessment in the neonatal...
- The National Institute of Child Health and Human Development awarded Providence College $554,233 on August 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to study interpersonal relationships and health behaviors among systems-involved youth. The research employs technology-mediated communication combined with ecological momentary assessment and interview methodologies to examine how caregivers, peers, and romantic partners influence dating...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services, awarded Yale University $5,063,609 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate how antiretroviral therapy exposure during pregnancy disrupts immune development and placental function in HIV-exposed uninfected infants. The research will use immunopeptidomics, transcriptomics, and functional co-culture assays...
- Federal Project Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded Brown University a $500,000 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) beginning September 1, 2025, and concluding August 31, 2027. The award funds research examining how state-level safety net program investments affect child health and development outcomes from birth through early adulthood. The...
- The National Institute of Child Health and Human Development (NICHD) awarded Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences School of Nursing, $3.297 million in federal research funding on August 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The research investigates mechanistic pathways linking gut microbiota alterations to neurodevelopmental impairment in HIV-exposed, uninfected infants (IHEU). The project...
- The National Institute of Child Health and Human Development awarded The Medical University of South Carolina $183,168 on June 4, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate lipid degradation in stored human milk and its effects on preterm gastrointestinal outcomes. The research evaluates how fatty acid-protein complex formation in donor milk drives preterm intestinal stress and mitochondrial toxicity, and determines whether...
The National Institute of Child Health and Human Development awarded Rhode Island Hospital $168,056 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to characterize variations in human milk microRNA profiles and examine relationships between microRNA composition and infant weight gain and immune system maturation. The research leverages an existing longitudinal study of 400 pregnant women and their infants in the Philippines, requiring no additional subject recruitment or sample collection. The work proceeds in two aims: first, determining human milk microRNA profiles in mothers who are underweight or infected with Schistosoma japonicum helminth, with the hypothesis that underweight mothers will show decreased growth-related microRNA and infected mothers will show downregulated immunomodulatory microRNA; second, examining impacts on infants, including associations between low levels of growth-related microRNA and infant wasting, and relationships between higher levels of immunoregulatory microRNA and more mature infant immune systems. The period of performance runs September 1, 2026, through August 31, 2031. Work is performed in Providence, Rhode Island. Rhode Island Hospital, a division of Lifespan Corporation and Brown University affiliate, holds the award as a clinical research institution with established strengths in infectious disease and pediatric research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $168.1k | 9/1/26 |